Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Ciência Plural |
Texto Completo: | https://periodicos.ufrn.br/rcp/article/view/27697 |
Resumo: | Introduction: Anorexia nervosa is characterized by an eating disorder with a typical clinical of food restriction and malnutrition. Objective: to verify the effectiveness of the use of the antipsychotic drugs olanzapine, quetiapine, risperidone in the weight gain of patients with this pathology. Methodology: 9 Randomized Clinical Trials (RCT) were used attached to the Medical Literature Analysis and Retrieval System Online/PubMed (MEDLINE) platform, all of which were analyzed based on inclusion and exclusion criteria made in pairs to carry out a Systematic Literature Review. Results: articles were evaluated through the Grading of Recommendatons Assessment Development and Evaluaton (GRADE) system. Discussion: Thus, among the main findings, the antipsychotic olanzapine appears as the most promising among risperidone and quetiapine. It has a positive effect on increasing the Body Mass Index (BMI) for a shorter period of time according to the Randomized Clinical Trials (RCT). Conclusions: further studies it is still needed to expand the field of treatment of eating disorders. Keywords: Eating disorder. Anorexia nervosa. Antipsychotics. |
id |
UFRN-4_b366bf9808010bce8341248de3f40978 |
---|---|
oai_identifier_str |
oai:periodicos.ufrn.br:article/27697 |
network_acronym_str |
UFRN-4 |
network_name_str |
Revista Ciência Plural |
repository_id_str |
|
spelling |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychoticsAnorexia nervosa y el efecto sobre el marco clínico con el uso de antipsicóticosANOREXIA NERVOSA E O EFEITO NO QUADRO CLÍNICO COM O USO DOS ANTIPSICÓTICOS Introduction: Anorexia nervosa is characterized by an eating disorder with a typical clinical of food restriction and malnutrition. Objective: to verify the effectiveness of the use of the antipsychotic drugs olanzapine, quetiapine, risperidone in the weight gain of patients with this pathology. Methodology: 9 Randomized Clinical Trials (RCT) were used attached to the Medical Literature Analysis and Retrieval System Online/PubMed (MEDLINE) platform, all of which were analyzed based on inclusion and exclusion criteria made in pairs to carry out a Systematic Literature Review. Results: articles were evaluated through the Grading of Recommendatons Assessment Development and Evaluaton (GRADE) system. Discussion: Thus, among the main findings, the antipsychotic olanzapine appears as the most promising among risperidone and quetiapine. It has a positive effect on increasing the Body Mass Index (BMI) for a shorter period of time according to the Randomized Clinical Trials (RCT). Conclusions: further studies it is still needed to expand the field of treatment of eating disorders. Keywords: Eating disorder. Anorexia nervosa. Antipsychotics.Introducción: La anorexia nerviosa se caracteriza por un trastorno alimentario con un cuadro clínico típico de restricción alimentaria y desnutrición. Objetivo: verificar la efectividad del uso de los medicamentos antipsicóticos olanzapina, quetiapina, risperidona em el aumento de peso de pacientes con esta patología. Metodología: Se utilizaron 9 Ensayos Clínicos Aleatorizados (RCT) adjuntos a la plataforma Medical Literature Analysis and Retrieval System Online / PubMed (MEDLINE), todos fueron analizados en base a criterios de inclusión y exclusión realizados en pares para realizar una Revisión Sistemática de la Literatura. Resultados: Los artículos fueron evaluados mediante el sistema Grading of Recommendatons Assessment Development and Evaluaton (GRADE). Discusión: Así, entre los principales hallazgos, el antipsicótico olanzapina aparece como el más prometedor entre la risperidona y la quetiapina. Tiene un efecto positivo en el aumento del índice de masa corporal (IMC) durante un período de tiempo más corto de acuerdo con los ensayos clínicos aleatorizados (RCT). Conclusiones: aun es necesario más estudios para ampliar el campo del tratamiento de los trastornos alimentarios. Palabras clave: Desorden alimenticio. Anorexia nerviosa. Antipsicóticos.Introdução: a anorexia nervosa caracteriza-se por um transtorno alimentar com quadro clínico típico de restrição dietética e desnutrição. Objetivo: verificar a eficácia do uso dos fármacos antipsicóticos olanzapina, quetiapina, risperidona no aumento ponderal de pacientes com tal patologia. Metodologia: utilizou-se de 9 Ensaios Clínicos Randomizados (ECR) anexados na plataforma Medical Literature Analysis and Retrieval System Online/PubMed (MEDLINE), sendo todos analisados a partir de critérios de inclusão e exclusão feitos aos pares para a realização de uma Revisão Sistemática de Literatura. Resultados: os artigos foram avaliados através do sistema Grading of Recommendatons Assessment Development and Evaluaton (GRADE). Discussão: desse modo, dentre os principais achados, o antipsicótico olanzapina aparece como o mais promissor entre a risperidona e a quetiapina. O mesmo apresenta efeito positivo no aumento do Índice de Massa Corpórea (IMC) durante um menor intervalo de tempo de acordo com os Ensaios Clínicos Randomizados (ECR). Conclusões: ainda se faz necessários novos estudos para ampliar o campo de tratamento dos transtornos alimentares. Palavras-Chave: Transtorno alimentar. Anorexia nervosa. Antipsicóticos.Portal de Periódicos Eletrônicos da UFRN2022-03-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.ufrn.br/rcp/article/view/2769710.21680/2446-7286.2022v8n2ID27697Revista Ciência Plural; v. 8 n. 2 (2022): Revista Ciência Plural; 1-122446-728610.21680/2446-7286.2022v8n2reponame:Revista Ciência Pluralinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNporhttps://periodicos.ufrn.br/rcp/article/view/27697/15422Copyright (c) 2022 Revista Ciência Pluralinfo:eu-repo/semantics/openAccessDias Rodrigues Araújo, RebecaPorto de Melo, RodolfoNunes Alves de Sousa, Milena2022-03-25T03:18:45Zoai:periodicos.ufrn.br:article/27697Revistahttps://periodicos.ufrn.br/rcpPUBhttps://periodicos.ufrn.br/rcp/oai||irisdoceu.ufrn@gmail.com2446-72862446-7286opendoar:2022-03-25T03:18:45Revista Ciência Plural - Universidade Federal do Rio Grande do Norte (UFRN)false |
dc.title.none.fl_str_mv |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics Anorexia nervosa y el efecto sobre el marco clínico con el uso de antipsicóticos ANOREXIA NERVOSA E O EFEITO NO QUADRO CLÍNICO COM O USO DOS ANTIPSICÓTICOS |
title |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics |
spellingShingle |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics Dias Rodrigues Araújo, Rebeca |
title_short |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics |
title_full |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics |
title_fullStr |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics |
title_full_unstemmed |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics |
title_sort |
Anorexia nervosa and the effect on the clinical framework with the use of antipsychotics |
author |
Dias Rodrigues Araújo, Rebeca |
author_facet |
Dias Rodrigues Araújo, Rebeca Porto de Melo, Rodolfo Nunes Alves de Sousa, Milena |
author_role |
author |
author2 |
Porto de Melo, Rodolfo Nunes Alves de Sousa, Milena |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Dias Rodrigues Araújo, Rebeca Porto de Melo, Rodolfo Nunes Alves de Sousa, Milena |
description |
Introduction: Anorexia nervosa is characterized by an eating disorder with a typical clinical of food restriction and malnutrition. Objective: to verify the effectiveness of the use of the antipsychotic drugs olanzapine, quetiapine, risperidone in the weight gain of patients with this pathology. Methodology: 9 Randomized Clinical Trials (RCT) were used attached to the Medical Literature Analysis and Retrieval System Online/PubMed (MEDLINE) platform, all of which were analyzed based on inclusion and exclusion criteria made in pairs to carry out a Systematic Literature Review. Results: articles were evaluated through the Grading of Recommendatons Assessment Development and Evaluaton (GRADE) system. Discussion: Thus, among the main findings, the antipsychotic olanzapine appears as the most promising among risperidone and quetiapine. It has a positive effect on increasing the Body Mass Index (BMI) for a shorter period of time according to the Randomized Clinical Trials (RCT). Conclusions: further studies it is still needed to expand the field of treatment of eating disorders. Keywords: Eating disorder. Anorexia nervosa. Antipsychotics. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-03-08 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.ufrn.br/rcp/article/view/27697 10.21680/2446-7286.2022v8n2ID27697 |
url |
https://periodicos.ufrn.br/rcp/article/view/27697 |
identifier_str_mv |
10.21680/2446-7286.2022v8n2ID27697 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.ufrn.br/rcp/article/view/27697/15422 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Revista Ciência Plural info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Revista Ciência Plural |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Portal de Periódicos Eletrônicos da UFRN |
publisher.none.fl_str_mv |
Portal de Periódicos Eletrônicos da UFRN |
dc.source.none.fl_str_mv |
Revista Ciência Plural; v. 8 n. 2 (2022): Revista Ciência Plural; 1-12 2446-7286 10.21680/2446-7286.2022v8n2 reponame:Revista Ciência Plural instname:Universidade Federal do Rio Grande do Norte (UFRN) instacron:UFRN |
instname_str |
Universidade Federal do Rio Grande do Norte (UFRN) |
instacron_str |
UFRN |
institution |
UFRN |
reponame_str |
Revista Ciência Plural |
collection |
Revista Ciência Plural |
repository.name.fl_str_mv |
Revista Ciência Plural - Universidade Federal do Rio Grande do Norte (UFRN) |
repository.mail.fl_str_mv |
||irisdoceu.ufrn@gmail.com |
_version_ |
1809455199520030720 |